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Scientific Opinion on safety and efficacy of coated granulated cobaltous 
carbonate monohydrate as feed additive for all species
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Cobalt(III) is a component of cobalamin. Its essentiality as trace element results from the capacity of certain 
animal  species  to  synthesise  cobalamin  by  the  gastrointestinal  microbiota.  Feeding  cobalt(II)  carbonate 
hydroxide (2:3) monohydrate up to the maximum authorised total cobalt in feed is safe for the target animals. 
Cobalt is predominantly excreted via the faecal route. Absorbed cobalt follows aqueous excretion routes. About 
43 % of body cobalt is stored in muscle; however, kidney and liver are the edible tissues containing the highest 
cobalt  concentrations  and  are  most  susceptible  to  reflect  dietary  cobalt  concentrations.  In  animals  with  the 
capacity  to  synthesise  cobalamin,  cobalt  is  also  deposited  in  tissues  as  vitamin  B12.  Cobalt(II)  cations  are 
genotoxic under in vitro and in vivo conditions. Cobalt(II) carbonate has carcinogen, mutagen and reproduction 
toxicant (CMR) properties. No data are available on the potential carcinogenicity of cobalt(II) following oral 
exposure.  However,  oral  exposure  may  potentially  entail  adverse  threshold-related  effects  in  humans.  The 
estimated population intake of cobalt most likely includes the contribution of foodstuffs from animals fed cobalt-
supplemented feedingstuffs. An increase in cobalt exposure by the use of cobalt-containing feed additives is 
therefore not expected. Considering the population exposure to cobalt, about 4–10 times lower than the health-
based  guidance  value,  no  safety  concern  for  the  consumer  is  expected  for  threshold  effects  of  oral  cobalt. 
Cobalt(II) carbonate is a skin and eye irritant, and a dermal and respiratory sensitiser. Its dust is a hazard to 
persons handling the substance. Exposure by inhalation must be avoided. The use of cobalt from any source at 
the authorised maximum content in feed does not provide a risk to the environment. The coated granulated 
cobalt(II) carbonate hydroxide (2:3) monohydrate is available for cobalamin synthesis in the rumen and therefore 
effective in ruminants; this conclusion is extrapolated to horses and rabbits. 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of coated granulated cobaltous carbonate monohydrate, as feed additive for all animal species.  
The only physiological role of cobalt in target animals is that of a component of vitamin B12. The 
significance of cobalt(II) as an essential trace element results from the capacity of certain animal 
species to synthesise sufficient quantities of vitamin B12 by the gastrointestinal microbiota. 
Feeding  supplemental  cobalt  from  cobalt(II)  carbonate  hydroxide  (2:3)  monohydrate  up  to  the 
maximum total cobalt content in feed currently set by European Union (EU) legislation is considered 
safe for the target animals. The margin of safety is around 10. 
The apparent absorption of cobalt from cobalt chloride measured in laboratory animals was in the 
range of 13 to 34 %. Cobalt is predominantly excreted via the faecal route. Absorbed cobalt follows 
aqueous excretion routes, via kidney but also via milk. About 43 % of body cobalt is stored in muscle; 
however, kidney and liver are the edible tissues containing the highest cobalt concentrations and most 
susceptible to increase such concentrations as a response to increased cobalt concentrations in feed. In 
animals with the capacity to synthesise cobalamin, cobalt is also deposited in tissues in the form of 
vitamin B12. Most cobalt in offal and muscle tissues of ruminants can be attributed to vitamin B12. The 
fraction  of  vitamin  B12-bound  cobalt  is  smaller  in  hindgut  fermenters  (horses  and  rabbits)  and 
considerably smaller in poultry and pork meat, and particularly in milk and eggs indicating dietary 
supply of cobalt as such.  
Correlations  between  cobalt/vitamin  B12  intake  at  physiological  feed  concentrations  and  tissue 
deposition as cobalt(II)/cobalt(III) could not be established owing to lack of data. Any prediction of 
the cobalt content of food of animal origin from dietary cobalt is therefore not possible at present. 
Cobalt(II) cations are considered genotoxic under in vitro and in vivo conditions. Cobalt(II) carbonate 
has CMR (carcinogen, mutagen and reproduction toxicant) properties. No data are available on the 
potential carcinogenicity of cobalt(II) following oral exposure either in humans or in experimental 
animals. However, oral exposure may potentially entail a number of adverse effects in humans (effects 
on heart, erythropoiesis and thyroid and prenatal development, as well as allergic dermatitis). For 
these threshold effects, the FEEDAP Panel developed a health-based guidance value of 0.0016 mg/kg 
body weight (bw) and day.  
The estimated population average intake of cobalt was reported to be 0.005–0.04 mg Co/day in the 
USA, 0.011 mg Co/day in Canada, 0.012 mg/day in the UK, and 0.029 mg Co/day in France. These 
figures most likely include already the contribution of foodstuffs from animals fed feedingstuffs that 
are routinely supplemented with cobalt(II) compounds. An increase of cobalt exposure resulting from 
the use of cobalt-containing feed additives is therefore not to be expected. 
Considering the population exposure to cobalt, which is about 4–10 times lower than the health-based 
guidance value, no safety concern for the consumer is expected for threshold effects of oral cobalt at 
the current intake level. However, considering the toxicological profile of cobalt(II) and its salts, and 
the uncertainties regarding the deposition and the speciation of cobalt (cobalt(II) or vitamin B12) in 
foodstuffs of animal origin, the FEEDAP Panel confirms its previous position that it would be prudent 
to limit the cobalt (cobalt(II) cation) supplementation of feedingstuffs to a level lower than the current 
maximum authorised. 
Cobalt(II) carbonate hydroxide (2:3) monohydrate is  considered as a skin  and eye irritant and as 
dermal and respiratory sensitiser. No information was available for the coated granulated additive. 
Considering the toxicological profile of cobalt(II) carbonate, its dust is a hazard to persons handling 
the substance. Exposure by inhalation must be avoided. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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The use of cobalt from any source at the currently maximum authorised concentration in feed will not 
result in a substantial increase of the concentration in the environment and no further environmental 
risk assessment is deemed necessary. 
The coated granulated cobalt(II) carbonate hydroxide (2:3) monohydrate is considered as a source of 
available cobalt for microbial synthesis of vitamin B12 in the gastrointestinal tract. The additive is 
therefore  considered  as  an  effective  nutritional  additive  for  ruminants.  This  conclusion  can  be 
extrapolated to horses and rabbits. 
The FEEDAP Panel made some recommendations particularly for (i) the restriction of the use of 
cobalt(II)-containing additives to ruminants, horses and rabbits, (ii) the reduction of the maximum 
total  cobalt  content  to  1 mg/kg  complete  feed  and  (iii)  the  limitation  of  handling  the  additive  to 
premixture industry. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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BACKGROUND  
Regulation  (EC)  No  1831/2003
4  establishes the rules governing the  Community  authorisation of 
additives for use in animal nutrition.  In particular, Article 10(2) of that Regulation specifies that for 
existing products within the meaning of Article 10(1), an application shall be submitted in accordance 
with Article 7, at the latest one year before the expiry date of the authorisation given pursuant to 
Directive 70/524/EEC for additives with a limited authorisation period, and within a maximum of 
seven years after the entry into force of this Regulation for additives authorised without a time limit or 
pursuant to Directive 82/471/EEC. 
The  European  Commission  received  a  request  from  Doxal  Italia  S.p.A.
5  for  re-evaluation  of 
authorisation of coated granulated cobaltous carbonate monohydrate, when used as feed additive for 
all animal species (category: Nutritional additives; functional group: compounds of trace elements).  
However, it is noted that the application does not exactly correspond to the existing authorisation 
(basic cobaltous carbonate monohydrate). 
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
applications to the European Food Safety  Authority (EFSA) as a grouped application under Article 
10(2) (re-evaluation of an authorised feed additive) . EFSA received directly from the applicant the 
technical dossiers in support of this application.
6 According to Article 8 of that Regulation, EFSA,  
after  verifying  the  particulars  and  documents  submitted  by  the  applicant,  shall  undertake  an 
assessment in order to determine whether the feed additive complies with the conditions laid down in 
Article 5. The particulars and documents in support of the application were considered valid by EFSA 
as of 16 November 2011. 
The additive ―Basic cobaltous carbonate monohydrate‖ had been authorised in the European Union 
(EU)  under  the  element  Cobalt-Co  for  all  animal  species  ―Without  a  time  limit‖  (Commission 
Regulation  (EC)  No  1334/2003)
7  and amendments.  Following the provisions of Article 10(1) of 
Regulation (EC) No 1831/2003 t he compound was included in the  EU Register of Feed Additives 
under the category ―Nutritional additives‖ and the functional group ―Compounds of trace elements‖.
8  
EFSA issued an opinion on the use of cobalt compounds as additives in animal nutrition (EFSA, 
2009a). More recently the FEEDAP Panel has delivered an opinion on the safety and efficacy of 
cobalt carbonate 46 % as feed additive for ruminants, horses and rabbits (EFSA, 2012a). 
TERMS OF REFERENCE  
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animal(s), consumer, user and the environment and the efficacy of the coated 
granulated cobaltous carbonate monohydrate when used under the conditions described in Table 1.
                                                       
4   Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5  Doxal Italia S.p.A.Via Mascagni 6. 20050 Sulbiate (MI) – Italy.  
6  EFSA Dossier reference: FAD-2010-0371. 
7  Commission Regulation (EC) No 1334/2003 of 25 July 2003 amending the conditions for authorisation of a number of 
additives in feedingstuffs belonging to the group of trace elements. OJ L 187, 26.7.2003, p. 11. 
8  European Union Register of Feed Additives pursuant to Regulation (EC) No 1831/2003, 
http://ec.europa.eu/food/food/animalnutrition/feedadditives/comm_register_feed_additives_1831-03.pdf Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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Table 1:  Description and conditions of use of the additive as proposed by the applicant 
Additive   Film granulated preparation of basic cobaltous carbonate monohydrate 
(E3) 
Registration number/EC 
No/No (if appropriate)  E8 
Category(-ies) of additive  3. Nutritional additives 
Functional group(s) of additive  b. Compounds of trace elements 
 
Description 
Composition, description  Chemical formula  Purity criteria 
(if appropriate) 
Method of analysis 
(if appropriate) 
Basic cobaltous carbonate 
monohydrate (E3) 
2CoCO3 . 
3Co(OH)2 . H2O  Cobalt min. 46%    UV spectroscopy 
 
Trade name (if appropriate)  - 
Name of the holder of 
authorisation (if appropriate)  - 
 
Conditions of use  
Species  or 
category  of 
animal 
Maximum 
Age 
Minimum content  Maximum content  Withdrawal 
period 
(if appropriate)  mg/kg of complete feedingstuffs 
All animal species 
and categories  -  -  2 mg cobalt (total)/kg  - 
 
Other provisions and additional requirements for the labelling 
Specific conditions or restrictions for 
use (if appropriate) 
- For use in animal nutrition only.  
- For use in premixtures and in feedingstuffs. 
- The additive shall contain cobalt in the form of basic cobaltous 
carbonate monohydrate prepared in order to limit dust emissions to a 
maximum of 2 mg (total dust) per filter (Stauber-Heubach test). 
Specific conditions or restrictions for 
handling (if appropriate)  - 
Post-market monitoring  
(if appropriate) 
No specific requirements other than the traceability and complaint 
system implemented in compliance with the requirements of 
Regulation No 183/2005. 
Specific conditions for use in 
complementary feedingstuffs  
(if appropriate) 
- 
 
Maximum Residue Limit (MRL) (if appropriate) 
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
-  -  -  - 
 
 Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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ASSESSMENT 
This  opinion  is  based  in  part  on  data  provided  by  a  single  company  involved  in  the 
production/distribution of cobalt containing compounds. It should be recognised that this data covers 
only  a  fraction  of  the  existing  cobalt-containing  additives.  The  Panel  has  sought  to  use  the  data 
provided together with data from other sources to deliver an opinion.  
1.  Introduction 
Cobalt (Co) is a metallic element occurring in the most common compounds in the +2 or +3 oxidation 
states. Cobalt(III) is the central atom of cobalamin (vitamin B12), representing about 4.3 % of the 
molecular weight. Cobalt salts have been commonly used for many years in animal nutrition. Six 
cobalt salts are currently authorised in the EU (Commission Regulation (EC) No 1334/2003)
9 as feed 
additives  ( cobalt  acetate  tetrahydrate,  basic  cobalt  carbonate  monohydrate ,  cobalt  chloride  
hexahydrate,  cobalt  nitrate  hexahydrate ,  cobalt  sulphate  monohydrate   and  cobalt  sulphate 
heptahydrate)  for  all  animal  species  with  a  total  maximum  content  of  2  mg  Co/kg  complete 
feedingstuff. 
The  current  application  is  for  coated  granulated  cobaltous  carbonate  monohydrate.  The  cobalt 
compound which is the subject of the assessment has been submitted for re-evaluation. 
EFSA commissioned a study by the University of Gent (Belgium) of se lected trace and ultratrace 
elements who submitted a technical report to EFSA (Van Paemel et al., 2010); cobalt was included in 
this study. Information from this report has been used in this opinion. 
A previous opinion of the FEEDAP Panel (EFSA, 2009a) on the risk assessment of the use of cobalt 
compounds in animal nutrition considered (i) the necessity of cobalt supplementation for the different 
target species including potential adverse effects of minimising/withdrawing cobalt supplementation 
on animal health, (ii) the safety for consumers of foods from animals treated with cobalt salts, and (iii) 
the safety of persons handling cobalt compounds as feed additives. The current opinion summarises 
and updates the relevant sections, for details see the above-mentioned opinion. 
In a previous opinion, the FEEDAP Panel (EFSA, 2009 a) reviewed the toxicological data of cobalt 
available in the public literature,  and adopted for threshold-related effects the health-based guidance 
value set by the US Agency for Toxic Substances and Disease Registry for intermediate oral exposure 
(≥ 365 days) (ATSDR, 2010). In an opinion of the French Food Safety Agency (formerly AFSSA and 
now  ANSES)  regarding  the  migration  of  cobalt  from  porcelain  oven  dishes  intended  to  come  in 
contact  with  food  (AFSSA,  2010),  AFSSA  considered  also  the  FEEDAP’s  2009  opinion.  In  the 
current opinion, the FEEDAP Panel considered this assessment together with others in the light of the 
recently adopted default values for  uncertainty factors (UFs) of the EFSA’s Scientific Committee 
(EFSA, 2012b). Since the proposal for a health-based guidance value is not in the focus of the terms of 
reference, this consideration is given in Appendix (Appendix B). 
1.1.  Other uses of cobalt 
At present no cobalt sources/forms are authorised in the EU in the manufacture of food supplements. 
The EFSA’s Scientific Panel on Additives and Nutrient Sources added to Food (ANS Panel) assessed 
the  safety  of  cobalt(II)  chloride  hexahydrate  for  nutritional  purposes  (EFSA,  2009b).  The  Panel 
considered that the proposed uses of this compound in food supplements were of safety concern.  
Cobalt is listed in the fertiliser Regulation as micro-nutrient essential for plant growth.
10 
In the USA, the following cobalt compounds are allowed in animal feeds:  cobalt acetate, cobalt 
carbonate, cobalt chloride, cobalt choline citrate complex, cobalt glucoheptonate, cobalt gluconate, 
                                                       
9  OJ L 187, 26.7.2003, p. 11. 
10 Regulation (EC) No 2003/2003 of the European Parliament and of the Council of 13 October 2003 relating to fertilisers. 
OJ L 304, 21.11.2003, p. 1. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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cobalt  oxide,  cobalt  sulphate,  cobalt  amino  acid  complex,  cobalt  amino  acid  chelate  and  cobalt 
proteinate (AAFCO, 2010). 
1.2.  Biological role of cobalt 
The FEEDAP Panel summarised in a previous opinion (EFSA, 2009a) the biological role of cobalt as 
follows:  
―The only known essential role of cobalt in animals and humans is being a component of vitamin B12 
as Co(III). Absorbed cobalt per se, Cobalt(II), is not known to have any biological function. 
Cobalt is an essential trace element for ruminants and horses, which can synthesise vitamin B12 in the 
digestive  tract  by  microbial  action.  The  efficiency  of  incorporation  of  cobalt  in  vitamin  B12  in 
ruminants is low and inversely related to cobalt intake. Incorporation rate may be characterized by a 
range of 3 to 15 %. Besides covering the requirements for vitamin B12 synthesis, cobalt may play a role 
in rumen fermentation by increasing fibre digestion from low quality forages. 
Non-ruminants require the intake of vitamin B12 because they lack the ability to synthesise the vitamin 
in  significant  amounts  by  digestive  tract  microbiota.  However,  pigs  and  poultry  are  known  to 
synthesise small amounts of this vitamin by hindgut bacteria, which is why coprophagous animals 
may receive some supply of vitamin B12 from microbial fermentation.‖ 
2.  Characterisation  
For compounds of trace elements, the element itself is considered the active substance. 
2.1.  Characterisation and identity of the additive 
The  coated  granulated  preparation(s)  of  cobaltous  carbonate  monohydrate,  based  on  basic  cobalt 
carbonate monohydrate (chemical formula: 2CoCO3 x 3Co(OH)2 x H2O; molecular weight: 534.7 Da; 
CAS No 51839-24-8; min. 46 % Co), contains up to 5 % cobalt, products with 1, 2 and 5 % cobalt are 
exemplarily introduced in the dossier. The product consists further of coating agents and dispersants 
(poly-oxy-ethylene, sorbitan monolaurate, glycerol polyethyleneglycol ricinoleate, polyethyleneglycol 
300,  sorbitol,  and  maltodextrin)  and  a  carrier  granule  (calcium  magnesium  carbonate,  calcium 
carbonate,  corn  cobs).  The  coat-granulating  agents  comply  with  the  EU  requirements  for  food 
additives and/or  the  European  Pharmacopeia and/or  JECFA  specifications  (see Appendix  C).  The 
content of coat-granulating agents depends on the target concentration of cobalt in the additive (target 
concentrations of 1, 2 and 5 % cobalt may require the addition of 2.3, 2.4 and 3.0 % coating agents, 
respectively, to obtain the desired quality of the granulated preparation). 
Batch to batch consistency was demonstrated for two production series of a 5 % cobalt-containing 
preparation.
11 Twelve and eight batches showed mean cobalt content of 5.22±0.14 % and 5.23±0.12 %, 
respectively. 
Three batches of the 5 % cobalt-containing additive were examined for heavy metals and arsenic, and 
one for dioxins.
12 The maximum levels for Cd (< 1 mg/kg), Pb (<10 mg/kg), and As (<10 mg/kg), for 
PCDD/F (0.32 ng WHO-TEQ/kg) and dioxin-like PCBs (0.021 ng WHO-TEQ/kg) appear to comply 
with EU legislation. But when considering that Directive 2003/32/EC refers to  compounds of trace 
elements (As  max 30, Pb max 100 and Cd max 10 mg/kg) and assuming that the basic cobalt 
carbonate is the only source of heavy metals and arsenic and dioxins, the upper bound values might be 
about 9 mg Cd, 91 mg Pb and 91 mg As/ kg basic cobalt carbonate, the later value being above the 
threshold of the Directive. A comparable excess could be calculated for dioxins (2.9 ng/kg basic cobalt 
carbonate vs. 0.5 ng/kg of the Directive). A protocol for routine screening of heavy metals and arsenic, 
                                                       
11  Technical Dossier/Section II/Annex 2.1.3.a. 
12 Technical Dossier/Section II/Annex 2.1.4.f. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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as well as a proposal for specification of the coated granulated additive (< 5 mg Pb/kg, < 5 mg Cd/kg 
and < 15 mg As/kg) is attached to the dossier. 
Mercury (4 8 mg/kg additive corresponding to 36 73 mg/kg basic cobalt carbonate) appears high 
(compared to other mercury thresholds, i.e. 0.1 mg/kg feed materials, 0.2 mg/kg mineral feed, 0.3 
mg/kg CaCO3), is, however, not regulated for compounds of trace elements by Directive 2003/32/EC. 
Upon request of EFSA, the applicant provided the internal specifications for the cobalt raw materials 
(<1 mg Co/kg) and for the carrier calcium magnesium carbonate (<0.3 mg/kg). Provided that internal 
control measures are in place, the values measured for mercury could hardly be explained. A second 
analysis of the same three batches in another certified laboratory resulted in <0.005 mg Hg/kg of the 
coated granulated preparation (5 % cobalt).
13 
Bulk density is 1290 g/L.
14 The median particle size determined by laser diffraction of three batches 
was 750 µm, no particles with a dia meter less than 100 µm were foun d, whereas in the basic cobalt 
carbonate used for the preparation of the coated granulated material all particles were below 50 µm.
15 
Dusting potential (Stauber-Heubach method; mg/50 g sample) was examined on the basis of the same 
20 batches as used for batch to batch consistency ;
16 the dust emission was 0.3±0.1  for the first 12 
batches,  and 0.2±0.1  for other  eight   batches  (corresponding to about  0.015  g/m³)  for the two 
production series. Mechanical stability of the granules un der compression (5 t/cm
2) was principally 
demonstrated, however, dusting potential increased from 15 to about 45 mg/m³. 
The feed additive grade basic cobaltous carbonate monohydrate is prepared by binding the cobalt-
compound onto the surface of the carrier granule coated forming agents and dispersants applied as 
liquids  in  a  low  shear  granulation  process.  The  coating  agents  throw  a  ―net‖  across  the  granule 
surfaces and the quantities used can vary from batch to batch. MSDS for the process ingredients were 
submitted. 
2.2.  Stability and homogeneity 
Stability studies are not required for inorganic compounds of trace elements.  
The capability of the coated granulated formulation of basic cobalt carbonate to form homogeneous 
mixtures was assessed in a complete feed for pigs for fattening (three batches, target concentration 2 
mg Co/kg).
17 The additive was incorporated via premixtures containing vitamins and trace elements. 
Twenty samples were analysed. The CVs for two sets of 10 samples each were 7.8 %. 
2.3.  Physico-chemical incompatibilities in feed 
According  to  the  current  knowledge,  no  incompatibilities  resulting  from  the  use  of  cobalt(II) 
carbonate, hydroxide (2:3) monohydrate in animal nutrition are likely to be expected. 
2.4.  Conditions of use  
The cobalt(II) carbonate, hydroxide (2:3) monohydrate is intended to be used as feed additive for all 
animal species at a maximum (total) concentration in complete feed of 2 mg Co/kg.  
2.5.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of cobalt (three 
compounds,  including  basic  cobaltous  carbonate  monohydrate)  in  animal  feed.  The  Executive 
Summary of the EURL report is in Appendix A. 
                                                       
13 Supplementary information/Annex 2-8. 
14 Technical Dossier/Section II/Annex 2.1.5.b. 
15 Technical Dossier/Section II/Annex 2.1.5.a. 
16 Technical Dossier/Section II/Annex 2.1.5.a. 
17 Technical Dossier/Section II/Annex I 20.2.4.2.a. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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3.  Safety 
The paragraphs below on the safety of cobalt for target animals and consumers have been taken and 
summarised from a previous FEEDAP opinion (EFSA, 2009a). Additional information, which updates 
the mentioned opinion, has been considered and referenced in the current opinion. 
3.1.  Safety for the target species 
3.1.1.  Dietary requirement 
A specific requirement for cobalt per se is not established. The dietary requirement/allowances of 
ruminants and horses for cobalt intended to optimise the vitamin B12 supply is in the range of 0.1–0.25 
mg/kg complete feedingstuffs.  
Considering the low cobalt average background levels in feedingstuffs (< 0.1–0.5 mg/kg dry matter 
(DM), plant feed materials showing lowest values), feed supplementation is generally needed to cover 
the requirement. In general, a cobalt supplementation of 0.3 mg/kg DM is considered sufficient.  
Other  animal  species  than  ruminants,  rabbits  and  horses  do  not  need  dietary  cobalt,  but  do  need 
vitamin B12. 
3.1.2.  Tolerance 
The tolerance of ruminants to cobalt is very high and greatly in excess of the requirements. The US 
National Research Council (NRC) set 25 mg/kg feed as maximum tolerable level of cobalt for cattle, 
poultry, sheep and horses and 100 mg/kg feed for swine (NRC, 2005). According to  current  EU 
legislation, feed for all animal species is not allowed to exceed 2 mg total Co/kg complete feed. 
Typical signs of chronic cobalt toxicity in most species are reduced feed intake and body weight, 
emaciation,  anaemia,  hyperchromaemia,  debility  and  increased  liver  cobalt  (NRC,  1980).  Cobalt 
toxicity  in  cattle  is  characterised  by  mild  polycythaemia,  excessive  urination,  defecation  and 
salivation, shortness of breath and increased haemoglobin (Hb), red cell count and packed cell volume 
(NRC, 1996). Sheep seem to be more resistant to cobalt overdoses than cattle, and young ruminants 
without rumen function are more sensitive to cobalt overdoses than adults. 
Therefore, it is considered unlikely that cobalt toxicity in target animals could be a major problem in 
practice.  However,  Murray  (2010)  reported  some  field  cases  of  cobalt  toxicosis  in  calves  and 
concluded that supplementation of animals with minerals should be based on evidence of deficiency 
supported by laboratory confirmation. Signs of chronic cobalt toxicity are similar in many respects to 
deficiency.  Administration  of  additional  or  higher  doses  in  order  to  compensate  the  apparent 
deficiency would further deteriorate the clinical symptoms. The author concluded that supplementing 
diets of non-deficient animals, and failure to adhere to recommended dosages, is at best wasteful but is 
also potentially fatal.  
Corrier et al. (1986) administered different cobalt doses from cobalt chloride hexahydrate (equivalent 
to 0, 120 and 180 mg/kg feed from days 1 to 70; and 0, 400 and 600 mg supplemental Co/kg diet from 
days 71 to 108) to adult sheep. The authors observed a numerical decrease in weight gain at both 
cobalt doses, but no differences in haematological or biochemical determinations. Neither gross nor 
microscopic lesions were found in the testes or other tissues. Cobalt concentration in liver and kidney 
increased from 0.09 (both tissues) to about 8.6 and 2.0 mg Co/kg wet tissue, respectively, without 
differences  between  the  two  cobalt  doses  administered.  However,  the  results  differ  from  other 
previous  studies  (Becker  and  Smith,  1951),  which  reported  that  daily  doses  of  between  4  and 
11 mg Co/kg bw caused anaemia, severe anorexia, weight loss, acute toxicosis and mortality. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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3.1.3.  Interactions in vivo 
There appears to be a considerable variation in cobalt tolerance in animals. Several dietary factors (e.g. 
protein, sulphydryl-compounds, iron, selenium and vitamin E) and age may affect the level of cobalt 
necessary to cause overt toxicosis (NRC, 2005).  
3.1.4.  Conclusions on the safety for species  
Feeding  supplemental  cobalt  from  cobalt(II)  carbonate  hydroxide  (2:3)  monohydrate  up  to  the 
maximum total cobalt content in feed set by current EU legislation is considered safe for the target 
animals. The margin of safety is around 10. 
3.2.  Safety for the consumer  
3.2.1.  Metabolic fate 
The metabolic fate of cobalt and vitamin B12 (cobalamin) was already described in a previous opinion 
of the FEEDAP Panel (EFSA, 2009a), and it is summarised below. 
In laboratory animals such as rats and mice, the reported apparent absorption of cobalt from cobalt 
chloride  was  in  a  range  of  13 34 %.  Cobalt  is  predominantly  excreted  via  the  faecal  route,  and 
includes  mainly  the  unabsorbed  fraction.  Absorbed  cobalt  follows  aqueous  excretion  routes,  via 
kidney but also via milk. Urinary cobalt is considered a good indicator of exposure to soluble cobalt, 
but not to insoluble cobalt compounds. 
The microflora of the rumen (of cattle, sheep and goat) and of the large hindgut fermenters (horses and 
rabbits) synthesize vitamin B12 if sufficient quantities of available cobalt were orally provided. Only 
about  40 %  of  the  apparent  ruminally  synthesised  cobalamin  reaches  the  lower  intestine.  The 
degradation products without vitamin B12 activity reaching the intestine are poorly absorbed. The 
intestinal  disappearance  (difference  between  duodenal  and  ileal  supply)  indicated  an  apparent 
absorption of cobalamin of about 45 %. 
In animals with the capacity to synthesise cobalamin, cobalt from orally administered cobalt(II) is also 
deposited in tissues in the form of vitamin B12. 
3.2.2.  Tissue deposition 
About 43 % of body cobalt is stored in muscles. However, kidneys and liver are the edible tissues 
containing the highest cobalt concentrations; these organs also reflect the cobalt intake. 
Among foodstuffs of animal origin, offal shows the highest cobalt content: liver with about 0.02 0.07 
mg/kg fresh weight (FW), followed by kidney with about 0.001 0.01 mg/kg FW. Meat is in the range 
of 0.001 0.02 mg/kg FW as are fillets of freshwater fish. Milk and eggs contain about 0.004 0.005 
mg Co/kg; dairy products like cheese and butter are relatively rich in cobalt (0.02 mg/kg FW). Most 
cobalt in offal and muscle tissue of ruminants can be attributed to vitamin B12. This fraction of vitamin 
B12-bound cobalt is probably already smaller in hindgut fermenters (such as horses and rabbits, since 
only cobalt not absorbed in the small intestine is available for vitamin B12 synthesis in the hindgut), 
and considerably smaller in poultry and pork meat (about 20 to 40 %) indicating dietary supply of 
cobalt as such. Eggs and milk contain even higher amounts of vitamin B12-unrelated cobalt (about 70 
and 95 %, respectively) indicating excretion of absorbed soluble cobalt. However, these are estimates 
with  several  uncertainties  due  to  methodological  reasons  (e.g.  poor  data  set,  analytical  methods). 
Correlations  between  cobalt/vitamin  B12  intake  at  physiological  feed  concentrations  and  tissue 
deposition could not be established by the FEEDAP Panel owing to lack of data. Any prediction of the 
cobalt content of food of animal origin from dietary cobalt is therefore not possible at present. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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3.2.2.1.  Quantitative relations 
Male  rats  were  given  a  protein  restricted  diets  for  eight  weeks  (Clyne  et  al.,  1988),  either  non-
supplemented or supplemented with 20 mg CoSO4x7H2O/kg body weight (~ 4 mg Co/kg). Cobalt 
supplementation resulted in a significant decrease in weight gain, and an increase of cobalt in the 
myocardium (1.615 vs. 0.051 mg/kg), muscle tissue (0.483 vs. 0.019 mg/kg) and serum (0.124 vs. 
0.001 mg/kg). 
Henry et al. (1997) studied on a total of 27 mature wethers (59.8 kg bw) the effect of increasing 
dietary cobalt concentrations (0, 20, and 40 mg supplemental Co/kg feed from CoSO4xH2O, the basal 
diet contained 0.17 mg Co/kg) on tissue deposition for 60 days. The addition of cobalt had no effect on 
feed intake. The cobalt concentration in liver (control 0.20 mg/kg DM) responded to increasing dietary 
cobalt (3.74 and 7.33 mg Co/kg DM with 20 and 40 mg supplemental dietary cobalt, respectively) as 
did kidney (0.77 vs. 3.27 and 4.82 mg/kg DM), muscle (0.13 vs. 0.59 and 1.26 mg/kg DM) and heart. 
3.2.2.2.  A survey of foodstuffs of animal origin in the USA 
Coleman  et  al.  (1992)  published  data  on  the  cobalt  concentration  of  muscle,  liver  and  kidney 
specimens in the USA, collected at slaughter from 2314 animals of 17 animal species/categories for 
one  year  (1985-1986).  They  analysed  muscle,  liver  and  kidneys  of  about  328  calves,  286 
heifers/steers, 95 bulls/cows, 162 lambs, 34 sheep, 318 pigs, 280 boars/sows, 311 young chickens, 306 
mature chickens, 61 turkeys and 11 ducks. The limit of quantification (LOQ) was 0.15 mg Co/kg 
tissue FW. They found quantifiable cobalt levels in about 1.9 % of muscle, 24 % of liver, and 15 % of 
kidney  specimens.
18  Mean values were between 0.20 and 0.23 mg Co/kg muscle (exception 1.92 
mg/kg for four specimens from heifer/steer), 0.22 and 0.27 mg Co/kg liver (exception 1.15 mg/kg for 
54  specimens  from  bull/cow)  and  between  0.22  and  0.28  mg  Co/kg  kidney  without  essential 
differences between animal species/categories.  When calculating the specimens without quantifiable 
cobalt concentrations, considering the LOQ (worst case assumption), mean cobalt concentrations  in 
muscle, liver, and kidney of 0.15, 0.17, and 0.16 mg Co/kg, respectively, could be suggested. 
3.2.3.  Toxicological studies 
The  FEEDAP  Panel  previously  reviewed  the  available  toxicity  data  (EFSA,  2009a).  The  Panel 
summarised: 
―According  to  Regulation  (EC)  No  790/2009  amending  Regulation  (EC)  No  1272/2008,  cobalt 
dichloride and cobalt sulphate are of low acute toxicity (category 4), but are classified as respiratory 
and skin sensitizers (category 1), as acute and chronic toxicants to the aquatic environment (category 
1) and as presumed human carcinogens by the inhalatory route (class 1B). Cobalt(II) cations are also 
considered  genotoxic  under  in  vitro  and  in  vivo  conditions.‖  No  data  are  available  in  the  open 
literature on the potential carcinogenicity of cobalt following the exposure via the oral route either in 
humans or in experimental animals.  
The EFSA´s ANS Panel concluded in 2009 that ―Given the toxicological profile of cobalt(II) chloride 
hexahydrate, including genotoxicity and carcinogenicity, the Panel concludes that the proposed uses of 
cobalt(II) chloride hexahydrate added for nutritional purposes in food supplements as a source of 
cobalt are of safety concern‖ (EFSA, 2009b). 
The most recent assessment has been published by the European Chemicals Agency (ECHA) in 2010 
as  support  documents  for  the  identification  of  cobalt(II)  carbonate,  cobalt(II)  diacetate,  cobalt(II) 
                                                       
18 Exact figures as follows: 
  - Muscle specimens (quantifiable/total): calf (5/327), heifer/steer (4/287), bull/cow (2/95), lamb (1/165), sheep (2/34), pig 
(10/324), boar/sow (2/280), young chicken (9/311), mature chicken (3/308), turkey (2/61), duck (4/111). 
  - Liver specimens (quantifiable/total): calf (107/327), heifer/steer (91/287), bull/cow (54/95), lamb (40/164), sheep (12/34), 
pig (58/324), boar/sow (82/281), young chicken (29/309), mature chicken (51/309), turkey (16/60), duck (17/111). 
  - Kidney specimens (quantifiable/total): calf (70/328), heifer/steer (31/286), bull/cow (9/95), lamb (25/162), sheep (7/34), 
pig (34/318), boar/sow (15/280), young chicken (47/311), mature chicken (43/306), turkey (5/61), duck (66/111). Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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dinitrate, cobalt(II) sulphate and cobalt dichloride as substances of very high concern (SVHC) because 
of  their  carcinogen,  mutagen  and  reproduction  toxicant  (CMR)  properties  (ECHA  2008;  ECHA 
2010a d). The support documents cover also the hydrated forms of the cobalt salts. 
For cobalt(II) carbonate (EC No: 208-169-4, CAS No: 513-79-1), cobalt(II) diacetate (EC No: 200-
755-8, CAS No: 71-48-7) and cobalt(II) sulphate (EC No: 233-334-2, CAS No: 10124-43-3), the 
following classification according to Regulation (EC) No 1272/2008
19 was made: 
May cause cancer by inhalation (carcinogen 1B), suspected of causing genetic defects (mutagen 2), 
may damage fertility (reproduction toxicant 1B). May cause allergy or asthma symptoms or breathing 
difficulties if inhaled, may cause an allergic skin reaction.  Very toxic to aquatic life, very toxic to 
aquatic life with long lasting effects. 
On 20
th December 2011, the ECHA published a recommendation
20 for the inclusions of substances in 
Annex  XIV  (―List  of  substances  subject  to  authorisation‖)  of  Regulation  (EC)  No  1907/2006,
21 
prioritising thirteen substances from the Candidate List of SVHC. Among them is cobalt(II) carbonate, 
cobalt(II) sulphate, cobalt(II) diacetate, cobalt(II) dinitrate and cobalt dichloride. 
3.2.4.  Assessment of consumer safety 
The FEEDAP Panel summarised in 2009 (EFSA, 2009a): 
―The estimated population average intake of cobalt was reported to  be 0.012  mg/day in the UK, 
0.005–0.04 mg Co/day in the US, 0.011 mg Co/day in Canada, and 0.029 mg Co/day in France. The 
FEEDAP Panel, based on its own calculations, concluded that the potential cobalt intake of consumers 
from food of animal origin would not exceed 14 µg/day.‖ 
The  estimated  population  intakes  most  likely  include  already  the  contribution  of  foodstuffs  from 
animals fed feedingstuffs routinely supplemented with cobalt(II) compounds. An increase of cobalt 
exposure by the use of cobalt containing feed additives is therefore not to be expected. 
Considering that dietary exposure to cobalt is about 4 10 times lower than the health-based guidance 
value (see Appendix B), no safety concern for the consumer is expected for threshold effects of oral 
cobalt at the current intake level. 
However,  considering  (i)  the  toxicological  profile  of  cobalt(II)  and  its  salts,  (ii)  the  scarcity  of 
deposition data, particularly for milk and eggs, and (iii) the uncertainties regarding the speciation of 
cobalt  (cobalt(II)  or  vitamin  B12)  in  foodstuffs  of  animal  origin,  the  FEEDAP  Panel  confirms  its 
previous position that it would be prudent to limit the cobalt (cobalt(II) cation) supplementation of 
feedingstuffs to a level lower than the current maximum authorised. 
3.3.  Safety for the users/workers 
Any exposure of users to the cobalt(II) salt under application may be of concern, considering the 
toxicological  profile  of  cobalt(II)  carbonate  and,  particularly,  its  CMR  properties.  It  should  be 
considered as a skin and eye irritant as well as a potential sensitiser to the skin and the respiratory 
tract. No information was available for the coated granulated additive. 
                                                       
19 Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, 
labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and 
amending Regulation (EC) No 1907/2006. OJ L 353, 31.12.2008, p. 1. 
20 http://echa.europa.eu/documents/10162/17232/backgroundoc_cobalt_carbonate_en.pdf 
21 Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the 
Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals 
Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation 
(EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 
93/105/EC and 2000/21/EC. OJ L 396, 30.12.2006, p. 1. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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Particle  size  (inhalable  and  respirable  fraction)  and  dusting  potential  of  the  cobalt(II)  salt  under 
application are of particular relevance.  
3.3.1.  Hazard by inhalation 
Laser  diffraction  analysis  did  not  identify  in  three  batches  on  the  coated  granulated  basic  cobalt 
carbonate particles of inhalable size (diameter of ≤ 100 µm). The dusting potential is consequently 
very low (highest value of 20 batches 0.5 mg/50 g, corresponding to 0.025 g/m³ air). 
For pulmonary effects, the ATSDR has developed a minimum risk level of 0.1 μg Co/m
3 air (ATSDR, 
2010). The data submitted indicate a dusting potential of the coated granulated basic cobalt carbonate 
(20 batches) of about 1 250 µg Co/m³ air.  
3.3.2.  Conclusions 
The coated granulated basic cobalt(II) carbonate is considered as a skin and eye irritant and as dermal 
and inhalatory sensitiser.  
The compound has a low dusting potential. However, it exceeds the thresholds set by the ATSDR. 
Due to the CMR properties of the additive, its dust is a hazard to persons handling the substance. 
Exposure by inhalation must be avoided. 
3.4.  Safety for the environment 
Based on the calculation method provided in the relevant EFSA technical guidance (EFSA, 2008), the 
highest increase of cobalt in soil is around 40 µg/kg after a one year application of manure assuming 
that 100 % of a dose (2 mg Co from any source/kg complete feed) will be excreted. According to the 
database of the Forum of European Geological Surveys,
22 the median total cobalt content in Europe is 
8.97 mg/kg
 in subsoil and 7.78 mg/kg
 in topsoil, with a range varying from < 3 to 170 mg/kg
 in 
subsoils and up to 249 mg/kg
 in topsoils.  
The  FEEDAP Panel  therefore concludes  that the  use  of  cobalt  from  any  source  at  the  currently 
maximum  authorised  dose  will  not  result  in  a  substantial  increase  of  the  concentration  in  the 
environment and no further environmental risk assessment is deemed necessary. 
4.  Efficacy 
The only known essential role of cobalt in animals and humans is being a component of vitamin B12 as 
cobalt(III). Absorbed cobalt per se, cobalt(II), is not known to have any biological function. 
The FEEDAP Panel previously concluded that monogastric animals (including poultry and fish) do 
not  require  Co  but  vitamin  B12  (EFSA,  2009).  Consequently,  there  is  no  need  for  any  cobalt 
supplementation to the feed for these animals.  
The ruminal microflora can synthesize vitamin B12, provided dietary cobalt is available in sufficient 
quantities. Consequently, the vitamin B12 requirement of these animals can be covered by dietary Co. 
The host metabolism of ruminants requires also only vitamin B12. A comparable conclusion may be 
drawn for horses and coprophagous rabbits (hindgut fermentation of vitamin B12), although there is a 
lack of quantitative data. 
4.1.  Bioavailability of cobalt compounds 
Kawashima et al. (1997) studied on the basis of a previous experiment (Henry et al., 1997) in three 
trials the relative bioavailability of seven cobalt sources in ruminants (sheep) compared to reagent 
grade CoSO4x6/7H2O (23.1 % cobalt). The basal diet provided adequate cobalt to the animals. Cobalt 
deposition in liver and kidney was taken as the parameter. The cobalt sources were cobalt carbonate 
                                                       
22 http://weppi.gtk.fi/publ/foregsatlas/article.php?id=15 Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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feed grade (FG, 45.2 % cobalt), cobalt carbonate reagent grade (RG, 48.4 % cobalt), cobalt heptonate 
(4.1 % cobalt), cobalt oxide (FG, 70 % cobalt), cobalt oxide (RG, 72.5 % cobalt) and a cobalt oxide by-
product (BP) (25.6 % cobalt, > 21.7 % manganese, 10 % zinc and 9 % calcium).  
Both  carbonates  were  more  available  than  the  oxides.  The  ranges  of  the  relative  figures  for 
bioavailability (cobalt sulphate= 100) were for carbonate FG 87 141 %, carbonate RG 68 133 %, for 
the oxide BP 37-58 %, for oxide FG 7 24 %, for oxide RG 0 7 %, and for the heptonate 80 92 %. 
4.2.  Efficacy studies/trials 
Efficacy trials are not required for compounds of trace elements already authorised as feed additives 
(Annex III, 3.4. Regulation (EC) No 429/2008).
23 
To demonstrate the availability of cobalt from the coated granulated additive, the applicant performed 
in vitro studies comparing the dissolution o f  cobalt(II) from the  coated  granulated  form with the 
original basic cobalt carbonate after 1, 2,5 and 10 minutes in buffer solutions at a pH values of 3.0, 6.0 
and 7.4. No differences between the two test substances were observed . It can therefore be concluded 
that the coated granulated additive releases the cobalt(II) salt under the pH conditions which can be 
found in the gastrointestinum.
24 
4.3.  Conclusions on efficacy 
Taking into account in vitro data provided by the applicant and the respective in vivo literature, the 
coated granulated cobalt(II) carbonate hydroxide (2:3) monohydrate is considered as an efficacious 
source of cobalt which is turn used for microbial fermentation of vitamin B12. Evidence of the efficacy 
of the compound under assessment is therefore given for ruminants and can be extrapolated to horses 
and rabbits. 
The  FEEDAP  Panel  reiterates  its  previous  conclusion  (EFSA,  2009a)  that  the  potential  cobalt 
supplementation to diets for ruminants, horses and rabbits of 0.3 mg/kg DM and a maximum content 
of 1 mg Co/kg complete feed is considered appropriate, taking into account that the cobalt background 
concentrations in feed materials do not exceed 0.5 mg/kg DM of complete feed. 
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
25  and  Good 
Manufacturing Practice. 
CONCLUSIONS AND RECOMMENDATIONS 
The additive under application is a cobalt(II) carbonate hydroxide (2:3) monohydrate, placed in the 
market as a coated granulated preparation. 
The only physiological role of cobalt(II) is being a component of vitamin B12. The significance of 
cobalt(II) as essential trace element results from the capacity of certain animal species to synthesise 
sufficient quantities of vitamin B12 by gastrointestinal microbes. 
CONCLUSIONS 
Feeding  supplemental  cobalt  from  cobalt(II)  carbonate  hydroxide  (2:3)  monohydrate  up  to  the 
maximum total cobalt content in feed currently set by EU legislation is considered safe for the target 
animals. The margin of safety is around 10. 
                                                       
23 OJ L 333, 22.05.2008. p.1. 
24 Technical Dossier/Section IV/Annex 4.1.2.a. 
25 OJ L 35, 8.2.2005, p. 1. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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The apparent absorption of cobalt from cobalt chloride measured in laboratory animals was in a range 
of  13  to  34 %.  Cobalt  is  predominantly  excreted  via  the  faecal  route,  and  includes  mainly  the 
unabsorbed fraction. Absorbed cobalt follows aqueous excretion routes, via kidney but also via milk. 
About  43 % of  body  cobalt  is  stored in  muscle;  however,  kidney  and  liver are the  edible  tissues 
containing the highest cobalt concentrations and most susceptible to increase such concentrations as a 
response  to  increased  cobalt  concentrations  in  feed.  In  animals  with  the  capacity  to  synthesise 
cobalamin, cobalt from orally administered cobalt(II) is also deposited in tissues in the form of vitamin 
B12.  
Most cobalt in offal and muscle tissues of ruminants can be attributed to vitamin B12. The fraction of 
vitamin  B12-bound  cobalt  is  smaller  in  hindgut  fermenters  (horses  and  rabbits)  and  considerably 
smaller in poultry and pork meat, and particularly in milk and eggs indicating dietary supply of cobalt 
as such. Correlations between cobalt/vitamin B12 intake at physiological feed concentrations and tissue 
deposition as Co(II)/Co(III) could not be established due to lack of data. Any prediction of the cobalt 
content of food of animal origin from dietary cobalt is therefore not possible at present. 
Cobalt(II) cations are considered genotoxic under in vitro and in vivo conditions. Cobalt(II) carbonate 
has CMR (carcinogen, mutagen and reproduction toxicant) properties. No data are available on the 
potential carcinogenicity of cobalt(II) following oral exposure either in humans or in experimental 
animals.  However,  oral  exposure  may  potentially  entail  a  number  of  adverse  effects  in  humans 
(cardiac  effects,  effects  on  erythropoiesis,  effects  on  thyroid,  developmental  effects  and  allergic 
dermatitis). For these threshold effects, the FEEDAP Panel developed a health-based guidance value 
of 0.0016 mg/kg bw and day (see Appendix B).  
The estimated population average intake of cobalt was reported to be 0.005–0.04 mg Co/day in the 
USA, 0.011 mg Co/day in Canada, 0.012 mg/day in the UK, and 0.029 mg Co/day in France. These 
figures  most  likely  include  already  the  contribution  of  foodstuffs  from  animals  fed  feedingstuffs 
routinely  supplemented  with  cobalt(II)  compounds. An  increase  of  cobalt  exposure  by  the  use  of 
cobalt containing feed additives is therefore not to be expected. 
Considering the population exposure to oral cobalt which is about 4–10 times lower than the health-
based guidance value, no safety concern for the consumer is expected for threshold effects of oral 
cobalt. 
Cobalt(II) carbonate hydroxide (2:3) monohydrate is  considered as a skin  and eye irritant and as 
dermal and respiratory sensitiser. No information was available for the coated granulated additive. 
Considering the toxicological profile of cobalt(II) carbonate, its dust is a hazard to persons handling 
the substance. Exposure by inhalation must be avoided. 
The  FEEDAP Panel  concludes  that  the  use  of  cobalt  from  any  source  at  the  currently  maximum 
authorised concentration in feed will not result in a substantial increase of the concentration in the 
environment and no further environmental risk assessment is deemed necessary. 
The coated granulated cobalt(II) carbonate hydroxide (2:3) monohydrate, is considered as a source of 
available cobalt for microbial synthesis of vitamin B12 in the gastrointestinal tract. The additive is 
therefore  considered  as  an  effective  nutritional  additive  for  ruminants.  This  conclusion  can  be 
extrapolated to horses and rabbits.  
RECOMMENDATIONS 
The FEEDAP Panel recommends the following corrections and improvements in the description of the 
additive under application:  
  The denomination of the additive should be changed to coated granulated cobalt(II) carbonate 
hydroxide (2:3) monohydrate, to describe a distinctive identity. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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  The authorisation should reflect the real cobalt content of the additive (1, 2 or 5 %) instead of 
the value proposed by the applicant (46 %). 
Particular  specifications  for  heavy  metals  and  arsenic  in  the  coated  granulated  additive  are  not 
considered  appropriate,  since  the  amount  of  cobalt  compound  in  the  additive  may  vary  and  the 
cobalt(II) carbonate, hydroxide (2:3) monohydrate must comply with the thresholds set by Directive 
2002/32. Moreover, it is recommended to introduce a maximum threshold for mercury (0.3 mg Hg/kg 
cobalt compound).  
The  FEEDAP  Panel  reiterates  its  recommendations  from  the  previous  opinion.  Considering  the 
toxicological profile of cobalt(II) containing compounds, the FEEDAP Panel recommends to minimize 
the  exposure  of  users  to  cobalt(II)  compounds  at  several  levels  of  feed  formulation  and  animal 
nutrition. 
The FEEDAP Panel recommends modifying the authorisation of cobalt compounds in feedstuffs by: 
  restricting  the  use  of  cobalt  compounds  as  additives  to  feed  for  ruminants  (except  milk 
replacer), horses and rabbits; 
  reducing the authorised total maximum cobalt content from 2 to 1 mg/kg complete feed for all 
species except fish;  
  limiting  cobalt  supplementation  in  feed  for  ruminants  (except  milk  replacer),  horses  and 
rabbits to a maximum of 0.3 mg Co/kg complete feed. 
No  negative  consequences  of  these  measures  on  animal  health  and  the  efficiency  of  animal 
production are expected. 
The  FEEDAP  Panel  recommends  further  a  modification  of  the  conditions  of  use  of  cobalt(II) 
containing compounds: 
  The incorporation into feed should be only allowed via premixtures considering (i) the low 
incorporation rate into feed and  (ii)  the better equipment  of premixture  manufacturers for 
handling hazardous substances.  
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APPENDICES 
APPENDIX A 
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for Feed 
Additives on the Method(s) of Analysis for Cobalt (E3)
26 
In  the  current  application  authorisation  is  sought  under  articles  4(1)  and  10(2)  for  Cobaltous  acetate, 
tetrahydrate; Cobaltous carbonate, basic Cobaltous carbonate, monohydrate; Cobaltous sulphate, heptahydrate 
under the category of "nutritional additives" functional group 3b (compounds of trace elements), according to the 
classification system of Annex I of Regulation (EC) No 1831/2003. Specifically, authorisation is sought for the 
use of the feed additives for all categories and species. 
The  Applicants  stated  minimum  total  cobalt  contents  of  23%  in  Cobaltous  acetate,  tetrahydrate;  45%  in 
Cobaltous  carbonate  and/or  basic  Cobaltous  carbonate,  monohydrate;  and  20%  in  Cobaltous  sulphate, 
heptahydrate. 
The feed additives are intended to be incorporated into premixtures, feedingstuffs and water. Applicants (FAD-
2010-0227 and FAD-2010-0371) suggested maximum levels of total cobalt of 2 mg/kg feedingstuffs and 1 mg/L 
water to comply with the limits set in Regulations (EC) No 1334/2003. Applicant (FAD-2010-0402) took into 
consideration the EFSA Scientific opinion recommending to reduce the maximum level of Cobalt to 1 mg/kg 
feedingstuffs. 
For the identification of the various cobalt compounds in the feed additives the EURL recommends the general 
identification tests of acetates, carbonates and sulphates, described in the European Pharmacopoeia (Monograph 
01/2008:20301). Additionally the EURL recommends crystallographic techniques, such as X-Ray diffraction, for 
the  characterisation  of  crystalline  structure  of  Cobaltous  acetate,  tetrahydrate;  Cobaltous  carbonate,  basic 
Cobaltous carbonate, monohydrate and Cobaltous sulphate, heptahydrate.  
For the determination of total cobalt in the feed additive, premixtures and feedingstuffs the Applicants submitted 
internationally recognised ring trial validated methods EN 15510 and CEN/TS 15621. Both methods are based 
on inductively coupled plasma atomic emission spectroscopy (ICP-AES), with or without pressure digestion. 
Similar performance characteristics were reported for the two methods mentioned above: – a relative standard 
deviation for repeatability (RSDr) ranging from 2.5 to 12%; - a relative standard deviation for reproducibility 
(RSDR) ranging from 11 to 26 %; and – a limit of quantification (LOQ) around 0.7 mg/kg feedingstuffs. Based 
on these performance characteristics the EURL recommends for official control the two CEN methods (EN 
15510  and  CEN/TS  15621),  based  on  ICP-AES,  to  determine  total  cobalt  content  in  the  feed  additive, 
premixtures and feedingstuffs. Furthermore, the EURL recommends the ring-trial validated CEN method EN 
ISO 11885, based on inductively coupled plasma optical (atomic) emission spectroscopy (ICP-AES) for the 
quantification of total cobalt in water. 
Further testing or validation of the methods to be performed through the consortium of National Reference 
Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not considered necessary. 
 
                                                       
26   The full report is available on the EURL website: http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-
CobaltGroup.pdf Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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APPENDIX B 
The FEEDAP Panel of EFSA adopted in 2009 a scientific opinion on the use of cobalt compounds as 
additives in animal nutrition (EFSA, 2009). In this opinion, the Panel also reviewed the literature on 
threshold related adverse effects of oral cobalt intake. The Panel noted that the exposure to cobalt via 
the  oral  route  may  potentially  entail  a  number  of  adverse  in  effects  in  humans  (effects  on  heart, 
erythropoiesis, thyroid and prenatal development as well as allergic dermatitis). An increase in the 
erythrocyte  number  in  humans,  obtained  by  orally  administering  cobalt  (as cobalt  chloride)  at  an 
average daily rate of about 1 mg/kg bw to volunteers for 22 days (Davis and Fields, 1958), was 
considered the most sensitive biological effect linked to repeated oral exposure to the metal. The 
FEEDAP Panel adopted the conclusion of the ATSDR that the lowest observed effect level (LOAEL) 
obtained from this study could be taken to derive a minimum risk level of 0.01 mg Co/kg bw and day 
for intermediate duration (≤ 365 days) of cobalt exposure, applying a UF of 100 (10 for intra-human 
variability and 10 for the use of a LOAEL) (ATSDR, 2004). The LOAEL of 1 mg Co/kg bw and day 
was  considered  as  confirmed  by  an  8-week  study  in  rats  administered  cobalt  chloride  which 
established a no observed adverse effect level (NOAEL) of 0.6 mg Co/kg bw and day (Stanley et al., 
1947).  
In an opinion of the French Food Safety Agency (formerly AFSSA and now ANSES) considering the 
migration  of  cobalt  from  porcelain  oven  dishes  intended  to  come  in  contact  with  food,  it  was 
concluded: With respect to the health-based guidance values applicable to cobalt and in light of the 
few available studies on oral exposure, the Tolerable Daily Intake could be between 0.0016 and 0.008 
mg/kg bw/day, for threshold toxic effects (AFSSA, 2010).  
In its opinion, AFSSA considered also the FEEDAP opinion (EFSA, 2009) and mentioned that an 
uncertainty factor could however have been applied to the ATSDR Minimum Risk Level value to take 
into account subacute to chronic exposure extrapolation. AFSSA continued indicating that the value 
used in the REACH guidance documents for this extrapolation is 6, which brings the (tolerable) daily 
oral intake (from 0.01 mg/kg bw down) to 0.0016 mg/kg bw.  
The AFSSA noted further that the use of the rat study by Stanley et al. (1947) with an inter-species 
factor of 4 (rats to human) and an intra-species factor of 10 leads to a final value of 0.016 mg/kg 
bw/day.  An  additional  factor  of  at  least  2  should  however  be  applied  to  take  into  account  the 
extrapolation from subchronic exposure (90 days) to chronic exposure (lifetime). This leads to a final 
value smaller than 0.008 mg Co/kg bw/day (the rat study lasted 56 days). 
The AFFSA added: However the genotoxicity data do not allow the possibility of non-threshold toxic 
effects to be ruled out. Lacking oral carcinogenesis studies, the Threshold of Toxicological Concern 
could be applied for this type of effect. 
Other health-based guidance values 
The Dutch National Institute of Public Health and the Environment (RIVM) derived a Tolerable Daily 
Intake  of  0.0014  mg  Co/kg  bw  and  day  from  a  LOAEL  of  0.04  mg  Co/kg  bw  and  day  for 
cardiomyopathy after intermediate exposure in beer drinkers applying a safety factor of 30 (3 for intra-
human variability and 10 for extrapolation to a NOAEL) (RIVM, 2001). 
The Expert Group on Vitamins and Minerals (EVM) based its guidance level of 0.023 mg/kg bw and 
day - which would not be expected to result in any adverse effects - on a LOAEL of 23 mg/kg bw and 
day obtained in a 13-week study in mice using spermatogenesis as endpoint (EVM, 2003). An UF of 
1000 was applied (10 for inter-species variation, 10 for inter-individual variation and 10 for LOAEL to 
NOAEL  extrapolation).  However,  AFSSA  considered  that  according  the  REACH  technical 
documents, the LOAEL-to-NOAEL extrapolation factor should be 3 (or 10), the inter-species factor 7 
(for mice), the subchronic-to-chronic exposure extrapolation factor 2 and the intra-species factor 10, 
which leads to a total factor 1400 to 420. The guideline value would then be between 0.0164 and 
0.0548 mg Co/kg bw/day. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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Cobalt health-based guidance values and population exposure to cobalt 
Table B1 shows the different health-based guidance values adopted by various scientific bodies and 
calculated for a 70-kg adult person (EFSA, 2012). 
Table B1. Cobalt health-based guidance values for a 70-kg person   
Scientific body  mg Co/day 
ATSDR/FEEDAP    0.700 
AFSSA lower value    0.112  
AFSSA higher value    0.560  
RIVM       0.098 
EVM      1.610 
AFSSA corrected EVM, low value    1.148 
AFSSA corrected EVM, high value    3.836 
 
Some available estimates of the population intake for cobalt are 0.012 mg Co/day and person from a 
Total Diet Study in the UK (MAFF, 1997), and about 0.011 mg Co/day and person for the US 
population  (ATSDR,  2004).  All  exposure  data  are  considerably  below  the  health-based  guidance 
values (Table B1).  
Assessment 
It should be noted that the minimum risk level derived by ATSDR/FEEDAP was not foreseen for 
lifetime  exposure.  Its  use  was  expressively  limited  to  an  intermediate  duration  (≤  365  days)  of 
exposure. The AFSSA calculation intends to extrapolate for lifetime exposure, which is different to the 
above  and  not  comparable.  However,  the  FEEDAP  Panel  acknowledges  the  need  to  derive  a 
harmonised guidance value for chronic exposure to cobalt.  
The FEEDAP Panel wishes to highlight that any extrapolation from a subacute study to a health-based 
guidance value for lifetime exposure is difficult and increases the margin of uncertainty. A recent 
guidance for this extrapolation from the EFSA’s Scientific Committee is now available (EFSA, 2012). 
AFSSA, ATSDR and the FEEDAP Panel agree that polycythaemia is the most sensitive endpoint for 
threshold cobalt effects. 
For the extrapolation from subchronic to chronic study duration in rodents, the EFSA’s Scientific 
Committee  recommends  the  use  of  an  UF  of  2,  considering  the  extent  of  investigations  usually 
performed in 90-day studies. The EFSA’s Scientific Committee indicated in its opinion that it was not 
in a position to propose default values for the extrapolation from subacute to chronic study duration in 
rodents, due to differences in the respective study designs. 
In  accounting  for  the  absence  of  a  NOAEL,  the  Scientific  Committee  recommends  to  use  the 
benchmark procedure. If the benchmark procedure cannot be applied to the critical toxicological study 
(as is the case, individual data of the publication of Davis and Fields (1958) are not accessible), the 
LOAEL approach might be used and an additional UF will be needed, the size of which should be 
determined on a case-by-case basis and justified. Several organisations recommend in their guidelines, 
e.g. Guidelines for drinking water quality (WHO, 2011), the application of an additional UF of up to 
10 to the LOAEL to derive a health-based guidance value.  
Considering the study on human volunteers (Davis and Fields, 1958) with a LOAEL of 1 mg Co/kg 
bw and day and applying the recommendations and data given in the Scientific Committee guidance 
document, the following UFs can be applied: 10 for inter human variability, 10 for extrapolation from 
subacute to chronic and 6 for extrapolation from LOAEL to NOAEL. The total UF is then 600. A 
health-based guidance for chronic exposure for threshold related toxic effects would be 0.0016 mg 
Co/kg bw and day (equivalent to 0.12 mg Co/day for an adult 70-kg person, figure rounded following 
the recommendations of the Scientific Committee).  Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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Considering the rat study (Stanley et al., 1947) with a NOAEL of 0.6 mg Co/kg bw and day and 
applying the Scientific Committee recommendations, the following UFs were applied: 10 for inter-
species variability, 10 for intra-species variability and 4 for extrapolation from subchronic (8-week 
study)  to  chronic.  The  total  UF  is  then  400.  A  health-based  guidance  for  chronic  exposure  for 
threshold related toxic effects would be 0.0015 mg Co/kg bw and day (equivalent to 0.1 mg Co/day 
for  an  adult  70-kg  person,  figure  rounded  following  the  recommendations  of  the  Scientific 
Committee). 
The values for a health-based guidance level for chronic exposure to oral cobalt for threshold related 
toxic  effects  derived  from  the  two  relevant  studies  considered  in  the  previous  FEEDAP  opinion 
(EFSA, 2009) are similar (0.0016 (derived from the human study, Davis and Fields, 1958) and 0.0015 
mg/kg bw and day (derived from the rat study, Stanley et al., 1947)). The value derived from the 
human study is equal to the AFSSA proposal.  
The FEEDAP Panel adopts 0.0016 mg Co/kg bw and day (corresponding to a daily intake of 0.12 mg 
for a 70-kg adult person) as a health-based guidance value. Considering the population exposure to 
oral cobalt which is about 4 to 10 times lower than the health-based guidance value, no safety concern 
for the consumer is expected for threshold effects of cobalt. 
The FEEDAP Panel principally agrees with AFSSA when noting that the genotoxicity data do not 
allow to rule out the possibility of non-threshold toxic effects for cobalt(II). However, applying the 
threshold of toxicological concern (TTC) concept (TTCgenotoxic 0.15 µg/person and day) would lead to 
0.0025 µg Co/kg bw and day (about thousand folds lower than the proposed health-based guidance 
value); for several reasons this seems inappropriate. Cobalt occurs naturally in food of plant and 
animal origin. The estimated population average intake of cobalt is reported to be in the range of 5 40 
µg/person and day. Even a complete withdrawal of cobalt from animal nutrition would not reduce the 
population exposure to the magnitude required for the TTCgenotoxic to be met.  
For some animal species (ruminants and, probably, horses and rabbits) cobalt is an essential trace 
element  for  vitamin  B12  synthesis.  A  (not  fully  quantifiable)  part  of  cobalt  in  animal  tissues  and 
products is cobalt(III) in cobalamin and, as such, is indispensable to human nutrition. Nevertheless, 
any reasonable measure to reduce cobalt(II) content in foodstuffs of animal origin should be taken. 
Considering (i) the toxicological profile of cobalt(II) and its salts, (ii) the scarcity of deposition data, 
particularly for milk and eggs, and (iii) the uncertainties regarding the speciation of cobalt (cobalt(II) 
or vitamin B12) in foodstuffs of animal origin, it would be prudent to limit the cobalt (cobalt(II) cation) 
supplementation of feedingstuffs generally at a lower level and to animals which convert cobalt(II) to 
cobalamin. Therefore the FEEDAP Panel recommends to the European Commission to modify the 
authorisation of cobalt compounds in feedstuffs by (i) restricting the use of cobalt compounds as 
additives to feed for ruminants (except milk replacer), horses and rabbits, (ii) reducing the authorised 
total maximum cobalt content from 2 to 1 mg/kg complete feed for all species except fish, and (iii) 
limiting cobalt supplementation in feed for ruminants (except milk replacer), horses and rabbits to a 
maximum of 0.3 mg Co/kg complete feed. 
Conclusions 
The  FEEDAP  Panel,  following  the  recommendations  of  the  Scientific  Committee,  applies  to  the 
LOAEL (based on polycythaemia) of about 1 mg/kg bw observed in a 22-day study on volunteers an 
UF of 600 (10 for inter human variability, 10 for extrapolation from subacute to chronic and 6 for 
extrapolation  from  LOAEL  to  NOAEL).  This  results  in  a  health-based  guidance  value  of  0.0016 
mg/kg bw and day for threshold effects of oral cobalt, corresponding to a daily oral intake of 0.12 mg 
Co for a 70 kg adult person. 
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APPENDIX C 
Specific purity criteria for the coat-granulating agents 
Polyoxolethylene (20) sorbitan monolaureate (E432) meets the purity criteria defined in Commission 
directive 98/86/EC of 11 November 1998 amending Commission Directive 96/77/EC laying down 
specific purity criteria on food additives other than colours and sweeteners. 
Glycerol polyethyleneglycol ricinoleate (E484) meets the purity criteria specified in the United States 
Pharmacopoeia  entry  for  Polyoxyl  35  castor  oil  and  the  European  Pharmacopoeia  entry  for 
macrogolglyceryl ricinoleate (monograph 01/2005:1082). 
Polyethylene glycol 300 comprises 100 % polyethylene glycol in accordance with Ph Eur monograph 
1444 and JECFA Monograph 316. 
Sorbitol meets the purity criteria specified for sorbitol liquid in Commission Directive 95/31/EC of 5 
July 1995 laying down specific criteria of purity concerning sweeteners for use in foodstuffs. 
Maltodextrin (food grade) has the specific purity criteria SO2 max 10 mg/kg and heavy metals max 0.5 
mg/kg. Cobaltous carbonate monohydrate (film granulated preparation) for all species 
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ABBREVIATIONS 
AAFCO  Association of American Feed Control Officials 
AFSSA  Agence Française de Sécurité Sanitaire des Aliments (French Food Safety Agency) 
ALT  alanine transaminase 
ANS  EFSA’s Scientific Panel on Additives and Nutrient Sources added to Food 
ANSES  Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du 
  Travail 
As  arsenic 
AST  aspartate transaminase 
ATSDR  Agency for Toxic Substances and Disease Registry 
bw  body weight 
Ca  calcium 
CAS  Chemical Abstracts Service 
Cd  cadmium 
CMR  carcinogen, mutagen and reproduction toxicant 
Co  cobalt 
Cr  chromium 
DM  dry matter 
EC  European Commission 
ECHA  European Chemicals Agency  
EFSA  European Food Safety Authority 
EU   European Union 
EURL  European Union Reference Laboratory  
EVM   Expert Group on Vitamins and Minerals  
FEEDAP  EFSA’s Scientific Panel on Additives and Products or Substances used in Animal Feed 
FG   feed grade 
FW  fresh weight 
Hb  haemoglobin 
HDL  high-density lipoprotein 
Hg  mercury 
Ht  haematocrit 
ICP-AES  inductively coupled plasma atomic emission spectroscopy 
LOAEL  lowest observed adverse effect level 
LOQ   limit of quantification 
MAFF   Ministry of Agriculture Food and Fisheries 
MCH  mean corpuscular haemoglobin 
MCHC  mean corpuscular haemoglobin concentration 
MCV  mean corpuscular volume 
MRL  maximum residue limit 
NRC  National Research Council  
NOAEL  no observed adverse effect level 
Pb   lead 
PCB  polychlorinated biphenyl 
PCDD  polychlorinated dibenzo-para-dioxin 
PCDF  polychlorinated dibenzofuran 
RBC  red blood cell 
REACH   Registration, Evaluation, Authorisation and Restriction of Chemicals 
RIVM   Dutch National Institute of Public Health and the Environment 
RG  reagent grade 
SVHC  substances of very high concern 
TTC  threshold of toxicological concern 
TEQ  toxic equivalent factor 
UF  uncertainty factor 
WBC  white blood cell 
WHO  World Health Organization 